---
title: "The pharmaceutical commercial sector is active against the trend, LBX hits the daily limit in the afternoon"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231162712.md"
description: "The AI medical concept continues to strengthen, driving the pharmaceutical commercial sector to be active in the afternoon. LBX reached the daily limit, while NEPTUNUS, JZJ, HRPC, SYPM, and Yifeng Pharmacy saw significant gains"
datetime: "2025-03-10T05:34:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231162712.md)
  - [en](https://longbridge.com/en/news/231162712.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231162712.md)
---

# The pharmaceutical commercial sector is active against the trend, LBX hits the daily limit in the afternoon

The AI medical concept continues to strengthen, driving the pharmaceutical commercial sector to become active in the afternoon. LBX reached the daily limit, while NEPTUNUS, JZJ, HRPC, SYPM, and Yifeng Pharmacy saw significant gains

### Related Stocks

- [301017.CN](https://longbridge.com/en/quote/301017.CN.md)
- [603939.CN](https://longbridge.com/en/quote/603939.CN.md)
- [000078.CN](https://longbridge.com/en/quote/000078.CN.md)
- [605266.CN](https://longbridge.com/en/quote/605266.CN.md)
- [603883.CN](https://longbridge.com/en/quote/603883.CN.md)
- [600829.CN](https://longbridge.com/en/quote/600829.CN.md)

## Related News & Research

- [09:24 ETHippocratic AI Announces Next Generation of Healthcare AI: Orchestrators Focused on Outcomes, Not Tasks](https://longbridge.com/en/news/295806535.md)
- [Influencers fear the AI 'Scarlet Letter'](https://longbridge.com/en/news/295206942.md)
- [Research Teams at Leading Institutions Choose B3IQ to Own, Run, and Monetize Their AI Stack](https://longbridge.com/en/news/295552766.md)
- [08:08 ETIntelliTek Health and Promevo Collaborate to Advance Trusted AI for Healthcare on Google Cloud](https://longbridge.com/en/news/295534362.md)
- [3 Japanese AI Healthcare Stocks Backed By Real Software Adoption](https://longbridge.com/en/news/295739485.md)